Larkspur Health LLC - Jan 6, 2022 Form 4 Insider Report for Larkspur Health Acquisition Corp. (ZVSA)

Role
10%+ Owner
Signature
/s/ Daniel O'Connor, Managing Member
Stock symbol
ZVSA
Transactions as of
Jan 6, 2022
Transactions value $
$0
Form type
4
Date filed
3/10/2022, 04:32 PM
Previous filing
Mar 10, 2022

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction ZVSA Class A Common Stock Other $0 +236K $0.00 236K Jan 6, 2022 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction ZVSA Class B Common Stock Other $0 +3.43K +0.3% $0.00 1.14M Jan 6, 2022 Class A Common Stock 3.43K Direct F2, F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 These shares are underlying units (each unit consisting of one share of Class A common stock and three-fourths of one warrant, each whole warrant exercisable to purchase one share of Class A common stock) acquired in a private placement by the Reporting Person in connection with the issuer's initial public offering and subsequent partial exercise of the underwriters' over-allotment option. The above refers to the shares of Class A common stock included in the units purchased.
F2 As described in the issuer's registration statement on Form S-1 (File No. 333-256056) (the "Registration Statement") under the section entitled "Description of Securities - Founder Shares," the shares of Class B Common Stock, par value $0.0001 per share, will automatically be converted into shares of Class A Common Stock, par value $0.0001 per share, at the time of the issuer's initial business combination, on a one-for-one basis, subject to certain adjustment described therein, and have no expiration date
F3 In connection with the partial exercise of the underwriters' over-allotment option, A.G.P./Alliance Global Partners transferred 3,427 shares to the reporting person for no consideration.